ARPA-H Launches Agentic AI Cardiovascular Program

The U.S. ARPA-H is soliciting proposals for ADVOCATE, a multiyear program to develop FDA-authorized agentic AI systems for cardiovascular care, expecting teams to deliver two agents and seek authorization within roughly three years, with a proposal-summary deadline of Feb. 27. Simultaneously, CMS is advancing interoperability standards and the FDA cleared Aidoc’s AI triage detecting 14 acute CT conditions, highlighting regulatory alignment.
Scoring Rationale
High regulatory and deployment significance with clear developer actions; reliance on mixed reporting sources limits absolute breakthrough claim.
Practice interview problems based on real data
1,500+ SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems